These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7260999)

  • 21. [Significance of the alpha lipoprotein-cholesterol level in healthy subjects and patients with myocardial infarct].
    Pados G; Kusztos D; Valyon M; Horváth P; Kéri Z
    Orv Hetil; 1980 Feb; 121(7):372-9. PubMed ID: 7375100
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the share of phosphatidylcholine in total phospholipid concentration in patients with ischaemic heart disease and after myocardial infarction (author's transl)].
    Votruba M; Schmidtová H; Rouchal J; Vacková V
    Cas Lek Cesk; 1981 Jul; 120(27):823-5. PubMed ID: 7261003
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ischaemic heart disease risk factor correlation in patients after myocardial infarction (author's transl)].
    Blazej V; Závada M; Müller J; Vykopal V; Artner P; Zurková M; Vanĕk J
    Cas Lek Cesk; 1979 Dec; 118(52):1620-4. PubMed ID: 396983
    [No Abstract]   [Full Text] [Related]  

  • 24. Lipid profile during the first 24 hours after myocardial infarction has significant prognostic value.
    Górecki A; Bednarz B; Jaxa-Chamiec T; Maciejewski P; Łukaszewicz R; Ceremuzyński L; Dyduszyński A
    Kardiol Pol; 2004 Mar; 60(3):229-36; discussion 237. PubMed ID: 15156218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum concentration of cholesterol and high- and low-density lipoprotein fractions in healthy persons and after myocardial infarct].
    Giec L; Kulejewski L; Giec-Fuglewicz G
    Kardiol Pol; 1981; 24(11-12):753-60. PubMed ID: 7341830
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lipid lowering treatment in secondary prevention following myocardial infarct].
    Paragh G; Balogh Z; Boda J; Mohácsi A; Kovács P; Polgár P; Wórum F; Kakuk G
    Orv Hetil; 1997 Jul; 138(29):1849-53. PubMed ID: 9280882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HDL lipids in men with obliterating atherosclerosis of the lower extremities (author's transl)].
    Zák A; Zapletalová J; Puchmayer V; Tvrzická E; Skorepa J
    Cas Lek Cesk; 1981 Feb; 120(7):189-93. PubMed ID: 7226186
    [No Abstract]   [Full Text] [Related]  

  • 28. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.
    Yilmaz H; Agachan B; Karaali ZE; Isbir T
    Int J Mol Med; 2004 Jun; 13(6):889-93. PubMed ID: 15138631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A significant temporal and quantitative relationship exists between high-density lipoprotein levels and acute ischemic stroke presentation.
    Russman AN; Schultz LR; Zaman IF; Rehman MF; Silver B; Mitsias P; Nerenz DR
    J Neurol Sci; 2009 Apr; 279(1-2):53-6. PubMed ID: 19195663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lipid profile in myocardial infarction.
    Radhakrishnan T; Narayanan L; Varkey CC; Srinivasan NG
    Indian J Biochem Biophys; 1974 Sep; 11(3):247-51. PubMed ID: 4469253
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neutral HDL, lipoproteins in patients with hyperlipidaemia and in reference group (author's transl)].
    Zák A; Zeman M; Tvrzická E
    Cas Lek Cesk; 1981 Jul; 120(26):792-6. PubMed ID: 7260997
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of cholesterol and phospholipids of HDL2, HDL3 and VHDL in patients with atherosclerosis and diabetes mellitus.
    Kajiyama G; Nakagawa M; Takata K; Nakao S; Miyoshi A
    Hiroshima J Med Sci; 1981 Sep; 30(3):175-82. PubMed ID: 7298368
    [No Abstract]   [Full Text] [Related]  

  • 33. [Does HDL-cholesterol protect against myocardial infarction?].
    Klose G; Greten H
    Med Klin; 1980 Jan; 75(2):67-71. PubMed ID: 7374603
    [No Abstract]   [Full Text] [Related]  

  • 34. Dynamics of serum lipid changes in acute myocardial infarction.
    Markiewicz K; Lutz W; Pelka W; Walasek L
    Acta Med Pol; 1976; 17(3):193-201. PubMed ID: 998331
    [No Abstract]   [Full Text] [Related]  

  • 35. [HDL-cholesterol in patients with gout (author's transl)].
    Yamanaka H; Watanabe T; Kawai T; Nishioka K; Sakurabayashi I; Mikanagi K
    Ryumachi; 1981 Mar; 21(1):38-41. PubMed ID: 7280873
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries.
    Graziani MS; Zanolla L; Righetti G; Nicoli M; Modena N; Dimitri G; Menegatti G; Vassanelli C
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):135-7. PubMed ID: 8490059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate effect of smoking on serum lipids and lipoproteins in patients with healed myocardial infarction.
    Garg JP; Chauhan LS; Gupta RC; Agrawal MP; Bhandari VM
    Indian Heart J; 1982; 34(2):81-3. PubMed ID: 7118145
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination methods and clinical significance of HDL-cholesterol (author's transl)].
    Fukui I
    Rinsho Byori; 1981 Nov; 29(11):1071-8. PubMed ID: 7334659
    [No Abstract]   [Full Text] [Related]  

  • 39. [Plasma HDL-cholesterol concentration in diabetics (author's transl)].
    Ueda Y
    Rinsho Byori; 1981 Nov; 29(11):1085-9. PubMed ID: 7334661
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on the clinical significance of serum HDL-chol and HDL-PL determination in stroke patient (author's transl)].
    Yoshida K; Wago K
    Rinsho Byori; 1980 Jul; 28(7):665-9. PubMed ID: 7463760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.